<DOC>
	<DOCNO>NCT02972580</DOCNO>
	<brief_summary>Longitudinal prospective observational study . This 24-month study possibility extend data time point . Initially baseline , 12 24 month follow study complete .</brief_summary>
	<brief_title>Characterization Clinical Skeletal Cardiac Impairment Carriers DMD BMD</brief_title>
	<detailed_description>Three cohort enrol study . The target population cohort genetically confirm DMD/BMD female carrier ( Cohort A ) . This cohort consist 150 DMD/BMD mother somatic carrier mutation DMD gene . The data collect cohort compare two control group ; Control Group B cohort 50 DMD/BMD mother NOT somatic carrier Control Group C cohort 50 age-matched healthy control . The inclusion Control Group B allow comparison group mother share emotional cognitive burden caring affect male without physical cognitive risk female carrier . The Control Group C offer robust data age-matched healthy cohort purpose comparison .</detailed_description>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<criteria>Age &gt; 18 year Cohort A require genetically confirm mutation DMD gene affect son Cohort B include DMD/BMD mother NO somatic mutation DMD gene Cohort C agematched healthy control normal CK level Able complete test English Able consent Subjects contraindication cardiac skeletal muscle MRI Subjects heart failure medication time enrollment Subjects steroid treatment Presence inherit neurologic disease comorbidity may affect ability complete study Has medical condition extenuate circumstance , opinion investigator , might compromise subject 's ability comply protocol require testing procedure compromise subject 's wellbeing , safety , clinical interpretability</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>